Goat Milk Based Infant Formula in Newborns: A Double-Blind Randomized Controlled Trial on Growth and Safety
| Autor: | T, He, F, Woudstra, F, Panzer, A, Haandrikman, H J, Verkade, L, van Lee |
|---|---|
| Přispěvatelé: | Center for Liver, Digestive and Metabolic Diseases (CLDM) |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Glia Maturation Factor
RISK Colic Milk Human Goats growth tolerability symptoms Gastroenterology stool characteristics infant formula weight gain ASSOCIATION SN-2 PALMITATE goat milk protein Milk Double-Blind Method OBESITY Pediatrics Perinatology and Child Health Animals Flatulence Humans Cattle Female |
| Zdroj: | Journal of Pediatric Gastroenterology and Nutrition, 75(2), 215-220. Lippincott Williams and Wilkins |
| ISSN: | 0277-2116 |
| Popis: | Objectives: We aimed to determine the growth and safety parameters in newborns fed a goat milk based infant formula (GMF) using a randomized double-blind trial, in which a cow milk formula (CMF) served as a control and a breast fed (BF) group as a reference. Methods: Healthy term infants (n = 218) aged up to 14 days were recruited from 25 European study centers and randomized to GMF or CMF. Weight, length, head circumference were measured at baseline, and at 14, 28, 56, 84, and 112 days at the study clinics. Adverse events were recorded and stool characteristics, reflux, fussiness, colic, and flatulence were self-reported by parents in 3-day diaries. Anthropometric measurements were transformed to WHO standardized age- and sex-adjusted z-scores. Analyses of covariance and linear mixed modeling were used to statistically analyze growth, while adjusting for potential confounders when studying the breast-fed group (n = 86). Results: Comparing the GMF to the CMF group, weight gain [mean difference 227.8 g (95% CI -16.6 to -439.0)] and z-scores for anthropometric measurements were similar after 112 days intervention. Infant formula groups showed greater mean (SD) weight z-scores than the BF group from 84 days onwards (GMF: 0.28 (0.84), CMF: 0.12 (0.88), BF -0.19 (1.02), P < 0.05), whereas length and head circumference z-scores were similar. Incidences of serious adverse events and reflux, fussiness, colic, and flatulence were similar among the three groups. Conclusion: Our data demonstrate that GMF provides adequate growth, has a good tolerability, and is safe to use in infants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text